ANIMAL HEALTH INDUSTRY NEWS-December

The animal health industry is witnessing significant developments worldwide, including strategic investments by L Catterton in Brazil's WeVets, new product launches like Virbac's Trilotab for dogs with Cushing's syndrome, and Ceva Animal Health's expansion of vaccine manufacturing facilities in France and Hungary to address global demands. Events such as Argentina's CIVA 2024 summit and Germany's EuroTier trade fair are bringing industry stakeholders together, while companies like Zoetis, MSD, and Dechra continue innovating with leadership appointments, partnerships, and technology-driven solutions in regions like Colombia, Latin America, and the U.S.

?? L Catterton announced that it has made a strategic investment in WeVets, a leading independent veterinary hospital group in Brazil operating 24-hour centers and diagnostic labs. Founded in 2020, WeVets has 15 hospitals and two labs in S?o Paulo and Rio Grande do Sul. (cnhinews.com).

?? The animal health company Zoetis was named the Champion of Champions in the "Best of Agribusiness 2024" awards. The winners were announced at an event in S?o Paulo. Overall, the award, organized by Globo Rural magazine, highlighted the work of companies from 21 different agribusiness segments. In 2021, Zoetis, a global leader in animal health, decided to exit the foot-and-mouth disease vaccine market in Brazil. Some considered this a risky move, as it is a lucrative niche. (oglobo.globo.com, Nov. 26th).

?? MCassab Nutrition and Animal Health appoints Mauricio Graziani as Executive Director. Mauricio Graziani is the new Executive Director of the Nutrition and Animal Health Division of the MCassab Group. With over 30 years of experience, he will lead the poultry, swine, aquaculture, beef cattle, dairy cattle, and pet food businesses. "My strategic focus is to ensure the continuity and sustainability of MCassab Group's historical success, focusing on profitable growth and execution excellence in the Nutrition and Animal Health Division in Brazil," says Mauricio. He has had a successful career in multinational companies, leading Phibro Animal Health as country manager over the past decade. The MCassab Nutrition and Animal Health division has operated in the Brazilian and international markets for over half a century, including a unit in China and strong presence in Latin America. The MCassab Group is approaching its centennial in 2028. (opresenterural.com.br, Nov. 18th).

?? CIVA 2024: The veterinary industry event brought together all segments of the chain. The Argentine Veterinary Industry Summit successfully held its 22nd edition at Parque Norte, Buenos Aires, Argentina. It brought together top representatives of laboratories, distributors, suppliers, and entities in the sector, participating in a high-quality program. Around 300 representatives from 110 companies, chambers, and institutions attended this event on November 21st, organized by Asociación de Ideas. The summit showcased this year's progress in products such as MOTIVAR and Mi Negocio Veterinario, as well as its services as an agency. (motivar.com.ar, Nov. 26th).

?? Zoetis Colombia appoints a new leader. A year ago, the U.S.-based Zoetis appointed Mariana Cestau, an Argentine, as head of its Chilean subsidiary after her extensive career in human health and devices industries. Now, the company follows the same strategy by naming Alejandra Santamaría as head of Zoetis Colombia. Santamaría previously worked at the British company AZ as Commercial Director and Business Support for the Andean Cluster, covering Colombia, Peru, Ecuador, and Venezuela. In Mexico, Irma Egoavil has led operations for over a year, while Sean Scally oversees operations in the Southern Cone, a role he has held for 17 years. (pharmabiz.com, Nov. 25th).

?? MSD Animal Health and Azul Airlines join forces in an innovative partnership to celebrate the importance of pets in their owners' lives. The initiative includes customizing an Azul airplane with Bravecto's colors and messages, highlighting essential care and protection for pets, even during travel. The launch featured an inaugural flight where brand-affiliated influencers were special guests, bringing their pets on board to reinforce the concept of celebrating every moment with pets. During the flight, passengers watched a special Bravecto video, showcasing product information and its role in animal health and welfare. All pet-owning passengers received an exclusive kit containing products and accessories for their animals. (dossiernet.com, Nov. 25th).

?? Virbac launches Trilotab, a new treatment for Cushing's syndrome in dogs. Trilotab by Virbac is a chewable tablet for the treatment of pituitary or adrenal-origin hyperadrenocorticism in dogs. Virbac announced the launch of Trilotab?, the first chewable trilostane tablet with flavor and divisibility for dogs. Trilotab? allows for dosage adjustments with just three presentations available in concentrations of 10mg, 30mg, and 60mg in boxes of 30 tablets. Cushing's syndrome is among the most frequently diagnosed endocrine disorders in dogs, affecting 1 to 2 out of every 1,000 dogs. Early diagnosis and treatment are key to controlling symptoms and preventing disease progression. (animalshealth.es, Nov. 25th).

?? Ceva Animal Health has announced a significant investment in a state-of-the-art vaccine manufacturing facility to enhance its global production capabilities. The new 7,000 m2 facility, located at its campus in Angers, France, underscores Ceva’s commitment to meeting the growing demand for animal health solutions worldwide. The new plant, equipped with cutting-edge technology, will focus on manufacturing vaccines for swine, poultry, and ruminants. This investment comes at a critical time as producers across the globe face mounting challenges, including biosecurity threats, emerging diseases, and the need for sustainable farming practices. (swineweb.com, Nov. 26th).

?? Ceva Saúde Animal, a market leader through its Companion Animal Unit, participated in the XXV International Symposium on Canine Visceral Leishmaniasis, organized by the Brasileish Group, reaffirming its commitment to innovation in animal health and welfare. During the event, held on November 23-24 in Belo Horizonte (MG), the company highlighted its solutions for leishmaniasis prevention and introduced a new treatment for the disease, MARBOX-LEISH?. (caesegatos.com.br, Nov. 26th).

?? Nexus Animal Health, a consultancy firm focused on the animal health industry in Latin America, is establishing new partnerships in the African continent, consolidating its expansion process during 2024. (Company press release).

?? Mervue Laboratories participated at the Centro de Convenciones in Punta del Este, Uruguay, during OVUM 2024, held November 12-14. (Ovum press release).

?? EuroTier, the leading international trade fair for professional animal farming and livestock management, was held in Hannover, Germany, from November 10-13. This innovation platform for the global animal production industry provided an overview of the latest advancements and set new standards for the farming industry. (EuroTier site).

?? Central Garden & Pet Company announced its fiscal year results, ending September 28, 2024. Net sales for the Pet segment were $1.83 billion, a year-over-year decrease of 2%, with organic net sales falling by 6%. (Company press release).

?? Dechra launches the Felimazole section in the Dechra Endocrinology App. The company, with over 20 years of commitment to veterinary education and support in endocrinology, introduced a new feline hyperthyroidism section. Previously, veterinarians used the app for diagnosing and treating dogs with Vetoryl (Cushing’s) and Zycortal (Addison’s). The new Felimazole section offers accessible information for diagnosing, interpreting diagnostic tests, and starting treatments for hyperthyroid cats. It also links to the Conecta platform, a one-stop shop for resources on feline hyperthyroidism. (portalveterinaria.com, Nov. 23rd).

?? Boehringer Ingelheim announced the launch of Vetmedin Solution, the first FDA-approved oral solution for managing congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). The solution joins the existing Vetmedin Chewable Tablets. (prnewswire).

?? Bimeda introduced MoxiSolv Injection (generic moxidectin), a ready-to-use formulation for beef and dairy cattle, available in a convenient, non-shattering 500 mL plastic bottle. (Company press release).

?? Biotech company Vaxinano announced an exclusive license agreement with Vetoquinol to develop its leading canine leishmaniasis vaccine candidate using Vaxinano's proprietary nanoparticle technology. (prnewswire).

?? Ceva Animal Health launched Ceva Genesys, an automated solution for accurate male and female broiler chick separation at hatch, aiming to improve flock homogeneity. (thepoultrysite).

?? Ceva Animal Health announced the construction of a new 7,000 sq. m vaccine manufacturing facility in Hungary, expanding Ceva Phylaxia's capacity. The plant will produce fermentation-based multicomponent inactivated vaccines for animals. (Feedstuffs).

?? Merck Animal Health secured FDA approval for Safe-Guard Aquasol (fenbendazole oral suspension), the first FDA-approved chicken dewormer for backyard flocks, designed specifically for home use. (Feedstuffs).

?? Elanco Animal Health agreed to pay a $15 million civil fine to resolve U.S. SEC anti-fraud charges, related to misleading investors about revenue growth and demand in 2019 and 2020. Elanco did not admit or deny the allegations. (Reuters).

BERNARDO OTERO Animal Health business Leadership in Latin America

CEO & Founder de NEXUS ANIMAL HEALTH

Follow us ?? www.animalhealthnexus.com

Or ?? Subscribe on LinkedIn https://www.dhirubhai.net/build-relation/newsletter-follow?entityUrn=6862344212038328321

?